Literature DB >> 20061934

Papillary squamous cell carcinoma, not otherwise specified (NOS) of the penis: clinicopathologic features, differential diagnosis, and outcome of 35 cases.

Alcides Chaux1, Fernando Soares, Ingrid Rodríguez, José Barreto, Cecilia Lezcano, José Torres, Elsa F Velazquez, Antonio L Cubilla.   

Abstract

There is a group of low-grade papillomatous squamous cell carcinomas (SCC) of the penis, collectively designated as "verruciform," that are difficult to classify. A proposal of classification grouped these tumors in warty (condylomatous), verrucous, and papillary carcinomas. Papillary SCC, not otherwise specified is the third distinctive type of penile low-grade verruciform neoplasms. We are presenting clinicopathologic features of 35 cases from 2 institutions. All specimens were penectomies or circumcisions. Mean age was 57 years. Sites of involvement were glans alone in 18 cases (51%), glans, coronal sulcus and foreskin in 13 cases (37%), glans and sulcus in 3 cases (9%), and foreskin in 1 case (3%). Papillary carcinomas were large (mean 5.6 cm) exophytic low-grade squamous neoplasms with hyperkeratosis and papillomatosis. Papillae were variable in length and shape. The tip was straight, undulated, spiky, or blunt. There was no koilocytosis. The interface between tumor and stroma was characteristically jagged and a moderate stromal reaction was evident in most cases. The majority of the tumors (94%) showed a low-grade histology with focally present poorly differentiated areas in 6% of the cases. The mean thickness of the tumor was 9.4 mm. The most commonly invaded anatomic levels were the corpus spongiosum and/or dartos (77% cases). Corpus cavernosum was invaded in 8 cases (23%). Vascular and perineural invasion were unusual. Frequent associated lesions were squamous hyperplasia, differentiated penile intraepithelial neoplasia, and lichen sclerosus (74%, 46%, and 34%, respectively). Nodal metastases were identified in 3 of 12 patients with bilateral groin dissections. Of the 20 patients followed, 18 were either with no evidence of disease (15 cases) or died from unrelated causes (3 cases). One patient was alive with evidence of systemic metastases and 1 died from disseminated penile cancer 32 months after original penectomy. In conclusion, papillary carcinomas were exophytic albeit, often deeply invasive low-grade neoplasms, with a low rate of nodal metastasis characterized by complex papillae, irregular fibrovascular cores, and jagged tumor base. Papillary SCC should be distinguished from other penile verruciform tumors, including verrucous and variants, warty and papillary basaloid carcinomas, and carcinoma cuniculatum. Helpful morphologic features for differential diagnosis are provided.

Entities:  

Mesh:

Year:  2010        PMID: 20061934     DOI: 10.1097/PAS.0b013e3181c7666e

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  5 in total

Review 1.  [Pathology and histopathological evaluation of penile cancer].

Authors:  A Erbersdobler
Journal:  Urologe A       Date:  2018-04       Impact factor: 0.639

2.  Mixed papillary-sarcomatoid carcinoma of the penis: report of an aggressive subtype.

Authors:  Graziele Bovolim; Walter Henriques da Costa; Gustavo Cardoso Guimaraes; Fernando Augusto Soares; Isabela Werneck da Cunha
Journal:  Virchows Arch       Date:  2017-07-08       Impact factor: 4.064

3.  Pulmonary papillary squamous cell carcinoma: a population-based analysis of incidence, treatment, and prognosis.

Authors:  Qingchen Yuan; Na Sun; Zibo Meng; Xiao Chen
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

4.  Warty Carcinoma Penis: An Uncommon Variant.

Authors:  Sushma Thapa; Arnab Ghosh; Santosh Shrestha; Dilasma Ghartimagar; Raghavan Narasimhan; O P Talwar
Journal:  Case Rep Pathol       Date:  2017-01-05

5.  Warty carcinoma of the penis: A clinicopathological study from South India.

Authors:  Marie Therese Manipadam; Suresh Kumar Bhagat; Ganesh Gopalakrishnan; Nitin S Kekre; Ninan K Chacko; Samuel Prasanna
Journal:  Indian J Urol       Date:  2013-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.